Articles

Highlights in genitourinary cancers

BJMO - volume 17, issue 8, december 2023

T. Vermassen PhD, A. Decruyenaere MD, D. De Maeseneer MD, S. Rottey MD, PhD

SUMMARY

The 2023 annual ESMO meeting again offered striking presentations about the latest trial updates in genitourinary cancers, including prostate, renal cell and urothelial cell carcinomas. This article will give an overview of the key highlights presented during this meeting in this setting.

(Belg J Med Oncol 2023;17(8):313–8)

Read more

Highlights in genitourinary cancers

BJMO - volume 17, issue 5, september 2023

T. Vermassen PhD, A. Decruyenaere MD, D. De Maeseneer MD, S. Rottey MD, PhD

SUMMARY

The 2023 annual ASCO meeting offered once more remarkable presentations about the last trial updates in renal cell, bladder, testicular and prostate cancer. This article will give an overview of the key highlights presented during this meeting in this setting.

(Belg J Med Oncol 2023;17(5):169–77)

Read more

Highlights in genitourinary cancers

BJMO - volume 16, issue 8, december 2022

A. Decruyenaere MD, S. Rottey MD, PhD, D. De Maeseneer MD, T. Vermassen PhD

The 2022 annual ESMO meeting again offered striking presentations about the last trial updates in genitourinary cancers, including prostate, renal cell and urothelial cell carcinomas. This article will give an overview of the key highlights presented during this meeting in this setting.

(Belg J Med Oncol 2022;16(8):372–9)

Read more

Highlights in genitourinary cancer

BJMO - volume 16, issue 5, september 2022

T. Vermassen PhD, A. Decruyenaere MD, S. Rottey MD, PhD, D. De Maeseneer MD

SUMMARY

The 2022 ASCO Annual Meeting again offered a variety of advancements in the treatment of genitourinary cancers. In this summary, some of the highlights in the field of renal, bladder and prostate cancer will be discussed, with a particular focus on studies with a potential impact on clinical practice.

(Belg J Med Oncol 2022;16(5):214–22)

Read more